President Biden has instructed the Department of Health and Human Services (HHS) and other top health agencies to formulate a strategic plan for regulating AI tools, which are currently widely utilized in hospitals, health insurance companies, and other healthcare ventures. A safety program will be established as part of this directive, to receive reports on AI-related hazards and unsafe practices and provide solutions for these issues.
This move is part of a larger order to establish standards for AI usage across the government. The directive is an attempt to strike a balance between managing the risks associated with AI and fostering innovation that benefits consumers. It supports initiatives against harmful practices and discrimination and encourages the provision of grants and funding for AI-related research, such as drug discovery.
The directive also includes a stipulation that any company developing a generative or foundational AI tool that could potentially harm public health must notify the government during the training phase of the model and share the results of its safety tests.
The HHS has been given a 180-day deadline to create a strategy to evaluate the quality of AI tools before they are deployed in the healthcare sector. This includes the development of performance evaluation and maintenance standards for AI models.
This initiative by the Biden administration highlights the increasing integration of AI technology in various sectors and the growing need for regulation and oversight to manage potential risks. It also underscores the importance of fostering and supporting beneficial AI innovation.
The directive demonstrates a proactive approach to risk management in the era of AI, highlighting the importance of balancing the need for technological innovation with the need for safety and ethical considerations. It also underscores the role of government in providing regulatory oversight in rapidly advancing technological fields.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
